Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Global Ship Lease Announces Annual Meeting of Shareholders
-
Anuma launches private AI with one memory across every leading model
-
Rubicon Organics to Report Q1 2026 Results; Announces Line of Credit Amendment
-
NOV Reports First Quarter 2026 Earnings
-
Performance Shipping Inc. Announces Filing of 2025 Annual Report on Form 20-F
-
Biomea Fusion Announces Positive 52-Week Results from Phase 2 COVALENT-112 Trial in Type 1 Diabetes Showing C-Peptide Improvement and Durability Following 12-Weeks of Icovamenib Treatment
-
European Residential Real Estate Investment Trust Announces Unitholder Approval and Anticipated Closing Date of Arrangement With Canadian Apartment Properties Real Estate Investment Trust
-
Heron Therapeutics to Report First Quarter 2026 Financial Results on Monday, May 11, 2026
-
Crypto News: Pepeto Opens New Presale Stage Whilst Cardano Price Prediction Questions the $1 Target
-
VCA Canada Earns 2026 Great Place To Work® Certification™
-
Taysha Gene Therapies to Present New Preclinical Data Supporting Construct Design of TSHA-102 for Rett Syndrome at the ASGCT 2026 Annual Meeting
-
Lexeo Therapeutics Announces Multiple Presentations at the 29th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
-
Crinetics Pharmaceuticals Announces the European Commission Approval of PALSONIFY® (Paltusotine) for the Treatment of Acromegaly in Adults
-
OMODA & JAECOO Global Sales Approach One Million as Nine-Country Media Put SHS to the Test in a Real-World Trial
-
One Million Units, Co-Created with Youth! OMODA & JAECOO's From Million To Annual Million Strategy Ignites the Future
-
Brown & Brown, Inc. announces first quarter 2026 results, including total revenues of $1.9 billion, an increase of 35.4%; flat Organic Revenue; growth of Organic Revenue with Contingents of 2.2%; dilu
-
Brown & Brown, Inc. announces first quarter 2026 results, including total revenues of $1.9 billion, an increase of 35.4%; flat Organic Revenue; growth of Organic Revenue with Contingents of 2.2%;
-
$20.6 Trillion Liquidity Migration: Why Zoomex is Redefining the Crypto Derivatives Landscape in 2026
-
Crypto News Today: Pepeto CoinMarketCap Listing Goes Live While BNB Price Prediction Points Toward $2,000
-
Canada's Newcomer Children Have an Academic Integration Gap. A Community-Owned Ontario Startup Just Partnered With Three School Boards to Close It
-
Apogee Minerals Announces Non-Brokered Private Placement Financing
-
Arbor Biotechnologies to Present Expansion of CNS Editing Platform Capabilities at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting
-
Premium Income Corporation Announces Class A Share Split
-
Seven Goranson Bain Ausley Attorneys Named to D Magazine’s 2026 Best Lawyers in Dallas
-
Cabaletta Bio Announces Multiple Upcoming Presentations, Including Data on Rese-cel without Preconditioning and Rese-cel with Automated Manufacturing, at the ASGCT 2026 Annual Meeting
-
North American Construction Group Ltd. First Quarter Results Conference Call and Webcast Notification
-
ElevateBio to Present Nine Abstracts Showcasing Advancements Across its Gene Editing Platform at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting
-
Auddia Announces Closing of $12 Million Public Offering
-
Tessera Therapeutics to Present New Preclinical Data Supporting In Vivo Program in Sickle Cell Disease and Advancements in In Vivo CAR-T Applications at the American Society of Gene and Cell Therapy 2
-
Aclaris Therapeutics to Provide Clinical Update on Key Biologic and Oral Inhibitor Programs on April 28, 2026
-
New Crypto Pepeto DeFi Exchange Hits Final Testing While Dogecoin Price Prediction Reaches $5 as Meme Rotation Picks Up
-
First Bank Announces First Quarter 2026 Net Income of $7.6 Million
-
Dyne Therapeutics Announces Upcoming Presentation Highlighting Robust CNS Activity in Nonhuman Primates with its FORCE™ Platform at 2026 ASGCT Annual Meeting
-
Voyager IV-Delivered CNS Gene Therapies Featured in Multiple Presentations at ASGCT 2026, Including Late Breaker on Tau-Targeted VY1706 for Alzheimer’s Disease
-
Editas Medicine to Present New Preclinical Data Demonstrating Progress of EDIT-401 as Potential Treatment for Hyperlipidemia at Upcoming Scientific Conferences
-
Freddie Mac Issues Monthly Volume Summary for March 2026
-
Asgard Therapeutics announces oral presentation at ASGCT 2026, showcasing advanced preclinical data on AT-108 – its first-in-class, off-the-shelf, gene-based cancer immunotherapy
-
CVRx to Report First Quarter 2026 Financial and Operating Results and Host Conference Call on May 11, 2026
-
Rgenta Therapeutics Announces Two Oral Presentations Highlighting Proprietary RSwitch Technology at the American Society of Gene and Cell Therapy (ASGCT) 2026 Annual Meeting
-
Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting
-
Umoja Biopharma Announces Unveiling of UB-VV500 in Upcoming Poster Presentation at the American Society of Gene & Cell Therapy Annual Meeting
-
Hillman Reports First Quarter 2026 Results
-
Addition Therapeutics Announces Multiple Oral and Poster Presentations at the American Society of Gene & Cell Therapy (ASGCT) 29th Annual Meeting
-
Montauk Renewables Schedules First Quarter 2026 Conference Call for Thursday, May 7, 2026, at 8:30 a.m. ET
-
Robin Energy Announces Final Results of Tender Offer for Common Shares
-
XCharge Files 2025 Annual Report on Form 20-F
-
Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting
-
Charlton Aria Acquisition Corporation Announces Extension of the Deadline for an Initial Business Combination
-
Cellectis Presents Epigenetic Editing Platform to Turn Genes Off Without Altering DNA at the ASGCT Annual Meeting
-
Gulf Resources, Inc. Receives NASDAQ Notice to Late Filing of Its Annual Report
